The SEC charged a medical device company and its founder with making false statements about a FDA approval for a key product.
The SEC charged a medical device company and its founder with making false statements about a FDA approval for a key product.
Orthofix International N.V. became the third medical device company to settle with FCPA enforcement officials this year as their sweep of the industry continues. Earlier Biomet Inc. and Smith & Nephew, Inc. also settled FCPA charges. Orthofix is a limited …
FCPA Enforcement Continues To Sweep The Medical Device Industry Read More »